Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
boston
boston blog main
boston top stories
clinical trials
life sciences
national blog main
rna interference
accelerated approval
acute hepatic porphyria
akcea therapeutics
aminolevulinic acid
andrew fire
craig mello
drugs
fda
givosiran
hereditary transthyretin amyloidosis
inotersen
john maraganore
national top stories
new york blog main
new york top stories
nobel prize
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
tafamidis
vyndaqel
What
alnylam
2
×
drug
medicine
ok
2
×
pharmaceuticals
rnai
afternoon
alnylam’s
approved
cleared
data
far
fda
gets
history
interference
landmark
making
market
nasdaq
new
onpattro
patisiran
rna
second
seek
specifically
speedy
Language
Current search:
alnylam
×
ok
×
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
